Showing results (1-10 of 1,244) with videos related to
Sort By:
Pageof 125
Clinical Science (London, England : 1979)|July 30, 2008
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerationsDavid Preiss, Naveed SattarCurrent Opinion in Lipidology|September 8, 2011
Statins and the risk of new-onset diabetes: a review of recent evidenceDavid Preiss, Naveed SattarHeart (British Cardiac Society)|November 16, 2007
Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidenceDavid Preiss, Naveed SattarClinical Endocrinology|December 11, 2008
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidenceDavid Preiss, Naveed SattarHepatology (Baltimore, Md.)|July 27, 2010
Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective dataNazim Ghouri, David Preiss, Naveed SattarAmerican Heart Journal|December 21, 2010
A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial designDavid Preiss, Naveed Sattar, John J McMurrayInternational Journal of Epidemiology|October 30, 2016
Applying metabolomics to cardiometabolic intervention studies and trials: past experiences and a roadmap for the futureNaomi J Rankin, David Preiss, Paul Welsh, et al.Diabetologia|April 27, 2016
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms?Naveed Sattar, James McLaren, Søren L Kristensen, et al.Clinical Science (London, England : 1979)|January 27, 2004
Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease?Naveed SattarF1000Prime Reports|July 4, 2014
Advances in managing type 2 diabetes: challenging old paradigms and developing new onesNaveed SattarPageof 125